Broker Research
June 11, 2025 / 10:10 IST
Reported Standalone quarterly numbers for Panacea Biotec are:Net Sales at Rs 67.90 crore in March 2025 down 15.52% from Rs. 80.37 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 12.39 crore in March 2025 down 804.38% from Rs. 1.37 crore in March 2024.
EBITDA stands negative at Rs. 12.48 crore in March 2025 down 274.55% from Rs. 7.15 crore in March 2024.
Panacea Biotec shares closed at 441.15 on June 09, 2025 (NSE) and has given -1.58% returns over the last 6 months and 234.26% over the last 12 months.
| Panacea Biotec | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 67.90 | 108.43 | 80.37 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 67.90 | 108.43 | 80.37 | | EXPENDITURE | | Consumption of Raw Materials | 59.37 | 28.16 | 26.09 | | Purchase of Traded Goods | 1.75 | -- | -- | | Increase/Decrease in Stocks | -34.10 | 10.15 | 0.94 | | Power & Fuel | -- | -- | -- | | Employees Cost | 27.26 | 23.78 | 23.29 | | Depreciation | 4.91 | 5.21 | 5.14 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 32.19 | 30.95 | 39.29 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -23.48 | 10.18 | -14.38 | | Other Income | 6.09 | 3.32 | 16.39 | | P/L Before Int., Excpt. Items & Tax | -17.39 | 13.50 | 2.01 | | Interest | 4.64 | 3.85 | 3.36 | | P/L Before Exceptional Items & Tax | -22.03 | 9.65 | -1.35 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -22.03 | 9.65 | -1.35 | | Tax | -9.64 | -- | 0.02 | | P/L After Tax from Ordinary Activities | -12.39 | 9.65 | -1.37 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -12.39 | 9.65 | -1.37 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.02 | 1.58 | -0.22 | | Diluted EPS | -2.02 | 1.58 | -0.22 | | EPS After Extra Ordinary | | Basic EPS | -2.02 | 1.58 | -0.22 | | Diluted EPS | -2.02 | 1.58 | -0.22 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
